Curis (CRIS) EBITDA Margin Growth (5y) (2015 - 2025)
Curis (CRIS) EBITDA Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
194,956.00 |
| Sep 30, 2025 |
-2,549.00 |
| Jun 30, 2025 |
-2,835.00 |
| Mar 31, 2025 |
-8,765.00 |
| Dec 31, 2024 |
-2,556.00 |
| Sep 30, 2024 |
-12,051.00 |
| Jun 30, 2024 |
-13,076.00 |
| Mar 31, 2024 |
-473.00 |
| Dec 31, 2023 |
-21,410.00 |
| Sep 30, 2023 |
-17,273.00 |
| Jun 30, 2023 |
-17,752.00 |
| Mar 31, 2023 |
-5,912.00 |
| Dec 31, 2022 |
-13,610.00 |
| Sep 30, 2022 |
16,443.00 |
| Jun 30, 2022 |
1,305.00 |
| Mar 31, 2022 |
-6,095.00 |
| Dec 31, 2021 |
4,329.00 |
| Sep 30, 2021 |
124,955.00 |
| Jun 30, 2021 |
19,836.00 |
| Mar 31, 2021 |
9,142.00 |
